SS

Sanjay Srivastava

Active Director Director DIN 11927967
DIN 11927967 First appointment Sep 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Srivastava

Data last updated:

Sanjay Srivastava is a Director at Chandan Healthcare Limited (since 2026). The company operates in Healthcare.

DIN 11927967
Primary Designation Director
Industry Healthcare
First Appointment 07 Sep 2026
Oldest Company Age 23 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chandan Healthcare Limited L85110UP2003PLC193493
Director07 Sep 20262003Active

Board colleagues of Sanjay Srivastava

Directorship timeline

Open interactive timeline →
Chandan Healthcare Limited
Premium access

Shareholding and investment profile for Sanjay Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Srivastava

Sanjay Srivastava currently holds 1 directorship: Chandan Healthcare Limited (Director, since 07 Sep 2026).

Sanjay Srivastava was first appointed on 07 Sep 2026 as Director at Chandan Healthcare Limited.

The current boards of Sanjay Srivastava's companies include Amar Singh (Chandan Healthcare Limited), Amit Gupta (Chandan Healthcare Limited), Asmita Singh (Chandan Healthcare Limited), Brahma Nand Bhartiya (Chandan Healthcare Limited), Rajeev Nain (Chandan Healthcare Limited), Vinay Lamba (Chandan Healthcare Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available